1. Limited Proteolysis of Cyclooxygenase-2 Enhances Cell Proliferation.
- Author
-
Saadi E, Sood R, Dromi I, Srouji R, Hatoum OA, Tal S, and Barki-Harrington L
- Subjects
- Animals, Cell Proliferation genetics, Chromatography, Liquid, Cyclooxygenase 2 genetics, Gene Expression Regulation, Neoplastic genetics, Gene Expression Regulation, Neoplastic physiology, HEK293 Cells, Humans, Immunoblotting, Immunoprecipitation, Mice, Mice, Transgenic, Proteolysis, Tandem Mass Spectrometry, Cell Proliferation physiology, Cyclooxygenase 2 metabolism
- Abstract
Accumulating evidence suggests that the cyclooxygenase-2 (COX-2) enzyme has additional catalytic-independent functions. Here we show that COX-2 appears to be cleaved in mouse and human tumors, which led us to hypothesize that COX-2 proteolysis may play a role in cell proliferation. The data presented herein show that a K598R point mutation at the carboxyl-terminus of COX-2 causes the appearance of several COX-2 immunoreactive fragments in nuclear compartments, and significantly enhances cell proliferation. In contrast, insertion of additional mutations at the border of the membrane-binding and catalytic domains of K598R COX-2 blocks fragment formation and prevents the increase in proliferation. Transcriptomic analyses show that K598R COX-2 significantly affects the expression of genes involved in RNA metabolism, and subsequent proteomics suggest that it is associated with proteins that regulate mRNA processing. We observe a similar increase in proliferation by expressing just that catalytic domain of COX-2 (ΔNT- COX-2), which is completely devoid of catalytic activity in the absence of its other domains. Moreover, we show that the ΔNT- COX-2 protein also interacts in the nucleus with β-catenin, a central regulator of gene transcription. Together these data suggest that the cleavage products of COX-2 can affect cell proliferation by mechanisms that are independent of prostaglandin synthesis., Competing Interests: The authors declare no conflict of interest
- Published
- 2020
- Full Text
- View/download PDF